NEW YORK (GenomeWeb) – Strand Life Sciences, a genomic software company, opened a CLIA-registered laboratory this week in Aurora, Colo., and has launched a next-generation sequencing-based pan-cancer test dubbed StrandAdvantage.

Strand also has a diagnostics laboratory in Bangalore, India — the Strand Centers for Genomics and Personalized Medicine — and has been offering the StrandAdvantage test through that laboratory for the last three years, but will now market it as a laboratory-developed test to community oncologists in the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.